Plunkett Research Online: Aquinox Pharmaceuticals

AQUINOX PHARMACEUTICALS (AQXP:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which .....



Aquinox Pharmaceuticals
Ticker: AQXP
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 604 629-9223
Fax: 1 778 331-4486
Address: 887 Great Northern Way
Suite 450
Vancouver, BC V5T 4T5 Canada

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmacies and Drug Stores
ContactsDescription
Barbara TroupinChief Medical Officer/Vice President, Divisional
David MainCo-Founder/President/CEO/Chairman of the Board/Director
See More
Aquinox Pharmaceuticals Inc is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting SH2-containing inositol-5'-phosphatase 1, or SHIP1, which .....See More See More

Auditor: Deloitte LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
20162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: